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Methionine aminopeptidase (MetAP) is a metallopro-
tease that removes the N-terminal methionine during
protein synthesis. To assess the importance of the
two MetAPs in Mycobacterium tuberculosis, we
overexpressed and purified each of the MetAPs to
near homogeneity and showed that both were active
as MetAP enzymes in vitro. We screened a library of
175,000 compounds against MtMetAP1c and identi-
fied 2,3-dichloro-1,4-naphthoquinone class of com-
pounds as inhibitors of bothMtMetAPs. It was found
that theMtMetAP inhibitors were active against repli-
cating and aged nongrowing M. tuberculosis. Over-
expression of either MtMetAP1a or MtMetAP1c in
M. tuberculosis conferred resistance of bacterial
cells to the inhibitors. Moreover, knockdown of
MtMetAP1a, but not MtMetAP1c, resulted in
decreased viability of M. tuberculosis. These results
suggest that MtMetAP1a is a promising target for
developing antituberculosis agents.INTRODUCTION
Mycobacterium tuberculosis (M. tuberculosis), the etiological
agent of tuberculosis, is among the oldest pathogens that have
affected humans globally, and the re-emergence of M. tubercu-
losis has become a primary public health burden (Dye, 2006;
Gandhi et al., 2006; Raviglione, 2003; Zignol et al., 2006). The
rise in multidrug-resistant and extensively drug-resistant strains
of M. tuberculosis has reduced the effect of current treatment
options (Cole et al., 1998; Fauci, 2008; Zhang, 2005). Thus, the
development of antibiotics with novel mechanisms of action is
essential to effectively treating patients with tuberculosis (TB).
Methionine aminopeptidase (MetAP) is a dinuclear metallo-
protease that removes the N-terminal methionine from nascent
proteins (Giglione et al., 2003; Lowther and Matthews, 2000).86 Chemistry & Biology 17, 86–97, January 29, 2010 ª2010 ElsevierMetAP is conserved in all life forms from bacteria to humans.
There are two classes of MetAPs, MetAP1 and MetAP2, which
differ in the presence of an internal polypeptide insertion
present within the catalytic domain of MetAP2 (Arfin et al.,
1995). Eukaryotes possess both classes, whereas prokaryotes
have homologs of either MetAP1 (eubacteria) or MetAP2 (arch-
aeabacteria) (Lowther and Matthews, 2000). Variants of MetAP1
are further classified as MetAP1a, MetAP1b, and MetAP1c
(Addlagatta et al., 2005b), which are distinguished by the exis-
tence of an N-terminal extension in MetAP1b and MetAP1c,
and a unique zinc finger domain inMetAP1b. Recently, we solved
the X-ray crystal structures of the apo- and methionine-bound
forms of M. tuberculosis MetAP1c (Addlagatta et al., 2005b).
Thestructure revealed theexistenceof a highly conservedproline
rich N-terminal extension in MtMetAP1c that is absent in
MtMetAP1a but has sequence homology with the linker region
of human MetAP1 (HsMetAP1) (Addlagatta et al., 2005a).
Genetic studies have shown that deletion of MetAP from
Escherichia coli and Salmonella typhimurium is lethal (Chang
et al., 1989;Miller et al., 1989). In yeast, deletion of eithermetAP1
ormetAP2 results in a slow-growth phenotype, whereas disrup-
tion of both genes is lethal (Chang et al., 1992; Li and Chang,
1995). In Caenorhabditis elegans, MetAP2 is essential for germ
cell development (Boxem et al., 2004). In mammalian cells,
bothHsMetAP1 and HsMetAP2 have been shown to be required
for cell proliferation (Bernier et al., 2005). In particular,HsMetAP2
is essential for endothelial cell growth and angiogenesis and
mediates the inhibition of endothelial cells by the fumagillin
family of natural products (Griffith et al., 1997; Sin et al., 1997;
Yeh et al., 2006). Recent studies have also shown that HsMe-
tAP1 is involved in regulating cell cycle progression in mamma-
lian cells (Hu et al., 2006).
The essential role of MetAPs in prokaryotes makes this
enzyme an attractive target for the development of new antibi-
otics. In prokaryotes, where protein synthesis begins with an
N-formylated methionine, peptide deformylase (PDF) catalyzes
the removal of the formyl group beforeMetAP removes the newly
unmasked N-terminal methionine (Giglione et al., 2003; Solbiati
et al., 1999). Unlike most other prokaryotes, M. tuberculosis
possesses two MetAPs, MtMetAP1a and MtMetAP1c, whichLtd All rights reserved
Figure 1. Sequence Comparison of MtMetAP1a, MtMetAP1c, HsMetAP1 and EcMetAP1
The alignment was generated using ClustalW (www.ebi.ac.uk). BothMtMetAPs share a 33% similarity, and the metal-chelating residues necessary for catalysis
are conserved (*). MtMetAP1a and EcMetAP1 lack the N-terminal extension with a PXXPXP motif present in MtMetAP1c AND HsMetAP1 (underlined).
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have less than 45% similarity to E. coli MetAP1 (EcMetAP1),
less than 48% similarity to human MetAP1 (hMetAP1), and less
than 30% similarity to human MetAP2 (hMetAP2). Given the
presence of the two MetAP genes in M. tuberculosis, it was
unclear whether inhibition of either or both MtMetAPs is suffi-
cient to inhibit TB growth.
Recently, we and others (Zhang et al., 2009) characterized both
MetAPs from M. tuberculosis strains CDC1551 and H37Rv,
respectively. In this study, we investigated the functional impor-
tance of the twoMtMetAPs using a combination of chemical and
genetic approaches. We began by overexpressing and purifying
the twoMtMetAPs to near homogeneity from E. coli. Biochemical
characterization revealed that both MtMetAPs are functional as
methionine aminopeptidases in vitro. Using a high-throughput
screening approach, we screened 175,000 compounds againstChemistry & Biology 17,MtMetAP1c and identified compounds with 2,3-dichloro-
1,4-naphthoquinone core structure as inhibitors. We found that
these inhibitors were active against both MtMetAP enzymes and
mycobacterial growth in culture. In addition, we obtained genetic
evidence that anMtMetAPs is likely the relevant target of the newly
discovered inhibitors inM. tuberculosis in culture.
RESULTS
Overexpression, Purification, and Characterization
of MtMetAP1a and MtMetAP1c
A BLAST search of the genome of M. tuberculosis (Cole et al.,
1998) revealed the existence of two orthologs of E. coli MetAP,
and their N-terminal extension suggested that they belonged
to MtMetAP1a and MtMetAP1c classes, respectively (Figure 1)
(Addlagatta et al., 2005b). Previously, we have succeeded in86–97, January 29, 2010 ª2010 Elsevier Ltd All rights reserved 87
Chemistry & Biology
Methionine Aminopeptidases as Anti-TB Targetscloning, overexpressing, and purifying recombinantMtMetAP1c
with an N-terminal poly-histidine tag for crystallographic studies
(Addlagatta et al., 2005b). Recombinant MtMetAP1a was over-
expressed and purified in a similar manner, except that the
expression vector pET-28b was used to append a C-terminal
poly-His tag on the protein. Both proteins were efficiently purified
to near homogeneity by immobilized metal affinity chromatog-
raphy using Talon resins. Upon purification, C-terminally poly-
His-tagged MtMetAP1a and N-terminally poly-His-tagged
MtMetAP1cwere seen at about 28 kDa and 32 kDa, respectively,
on Coomassie blue-stained SDS-polyacrylamide gels (Figures
2A and 2B). The average yield from 1 liter of E. coli culture for
MtMetAP1a and MtMetAP1c were 4.3 and 13 mg, respectively.
The enzymatic activities of the purified M. tuberculosis
MetAPs were assessed using a chromogenic substrate (Met-
Pro-pNA) in a coupled enzymatic assay with proline aminopepti-
dase as the coupling enzyme (Zhou et al., 2000). Both purified
recombinant proteins were found to be catalytically active in
this assay (Figure 2C). The kinetic constants for MtMetAP1a
andMtMetAP1c were determined by measuring enzyme activity
at different substrate concentrations ranging from 0 to 800 mM.
The Km for the artificial substrate was similar for both enzymes,
whereas the kcat for MtMetAP1c was 10-fold higher than that
for MtMetAP1a (Table 1).
Using the same enzymatic assay, we also determined the
effects of temperature on both enzymes (see Figure S1 available
online). The temperature profile of MtMetAP1a gave a bell-
shaped curve, with an optimal temperature of 42C. In contrast,
the activity of MtMetAP1c increased by smaller increments as
temperatures were increased from 4C to 50C before loss of
activity was seen at 65C. These results suggested that
MtMetAP1c had a slightly higher thermostability than did
MtMetAP1a. The pH profiles of bothMtMetAPswere determined
by measuring the enzymatic activity in different buffers. The
optimal pH for both MtMetAPs was found to be 8.0 using
50 mM HEPES as buffer (Figure S2). It is noteworthy that
MtMetAP1a had optimal activity from pH 6.5 to pH 8.0, whereas
MtMetAP1c had a much steeper decline in activity upon pH
changes from 8.0.
Because the physiological metal cofactor for MetAPs remains
controversial, we determined the metal dependence of the two
MtMetAPs. BothMtMetAPs were found to be active in the pres-
ence of Co2+ or Mn2+. For MtMetAP1c, concentration-depen-
dent inhibition was observed in the presence of increasing
amounts of CoCl2 (Figure S3A). In contrast,MtMetAP1c retained
its optimal activity in the presence of 0.1–10 mM of Mn2+, and
only a slight decrease in activity was seen when Mn2+ concen-
tration was increased beyond 100 mM (Figure S3B). Unlike
MtMetAP1c, MtMetAP1a showed optimal activity at 10 mM of
Co2+ (Figure S3C) and 0.1–1 mM of Mn2+ (Figure S3D).
Identification ofMtMetAP Inhibitors via
High-Throughput Screening
In collaboration with ASDI Inc., we screened a structurally
diverse small molecule library of 175,000 compounds against
MtMetAP1c at a final concentration of 30 mM in 384-well plates
using the coupled enzymatic assay (Zhou et al., 2000). A total
of 439 hits were identified that exhibited greater than 40% inhi-
bition of MtMetAP1c at a final concentration of 10 mM. Interest-88 Chemistry & Biology 17, 86–97, January 29, 2010 ª2010 Elsevieringly, a number of the hits were found to contain 2,3-dichloro-
1,4-napthoquinone core structure. We acquired a total of 28
structural analogs for structure-activity relationship studies
(Table 2). For MtMetAP1a, we found that substitutions to the 2,
3-dichloro positions reduced activity, except for the 2,3-dibromo
derivative (compound 20; Table 2). In contrast,MtMetAP1c toler-
ated both fluorophenoxy and dibromo substitutions to the 2,3-
dichloro positions (compounds 21, 22, and 20, respectively)
(Table 2). In addition, we also determined the effects of some
naturally occurring 1,4-naphthoquinones and vitamin K deriva-
tives (Table 2) against both MtMetAP1a and MtMetAP1c. None
of them was active against either MtMetAP enzyme. Among all
analogs we obtained and tested, 2,3-dibromo-1,4-naphthoqui-
none (compound 20) was found to be most potent against
both MtMetAP1a and MtMetAP1c with IC50 values of around 1
mM (Table 2).
Next, we determined the effects of the most potent inhibitors
on the growth M. tuberculosis in culture. Compounds 4 and 20
were found to be most potent against M. tuberculosis with
minimum inhibitory concentration (MIC) values of 10.0 and
10.0–25 mg/mL, respectively (Table 3). Interestingly, the other
analogs with slightly higher IC50 values for either MtMetAP1c
(compounds 2 and 3) or MtMetAP1a (compounds 21 and 22)
showed about a two-fold increase in MIC values (Table 3). In
addition to replicating M. tuberculosis, we also tested these
MtMetAP inhibitors in agednongrowingM. tuberculosis (Table 3).
Interestingly, the active inhibitors, compounds 4 and 20,
were equally effective against the aged non-growing form of
M. tuberculosis as the replicating form.
Overexpression of MtMetAP1a or MtMetAP1c Confers
Resistance to M. tuberculosis to the Newly Identified
MetAP Inhibitors
If either of theMtMetAPs is the target of the inhibitors in vivo, it is
expected that their overexpression will cause resistance. To per-
turb the cellular levels of MtMetAPs, we first cloned each of the
mycobacterial MetAP1s into pSCW35DsigF (Figure 3), a vector
whose promoter is regulated by acetamide (Pace). This vector
also has an attP site that allows for stable integration of a single
copy of the plasmid into the attB site in the chromosome of
M. tuberculosis (Raghunand et al., 2006). The entire ORFs of
MtMetAP1a and MtMetAP1c genes were amplified by PCR
from M. tuberculosis strain CDC1551 genomic DNA and were
then subcloned into pSCW35DsigF vector in the sense orienta-
tion. The pSCW35-(MtMetAP1a) and pSCW35-(MtMetAP1c)
clones were verified by DNA sequencing.
To overexpress MtMetAP1a and MtMetAP1c in M. tubercu-
losis, we constructed knock-in strains for both MtMetAPs by
transforming M. tuberculosis CDC1551 with pSCW35DsigF-
(MtMetAP1a) and pSCW35DsigF-(MtMetAP1c), respectively. In
addition, we also transformed M. tuberculosis with a control
empty plasmid, pSCW35DsigF. All three transformants were
grown until early logarithmic phase, and expression was induced
by addition of 0.2% acetamide followed by incubation for an
additional 24 hr. To confirm that the levels of both MtMetAP1s
were increased, we used real-time quantitative PCR to quanti-
tate the transcript levels of both enzymes. The mRNA levels of
MtMetAP1a and MtMetAP1c were about 4.5- and 6-fold higher
than that of the control, respectively (Figure 3B). We examinedLtd All rights reserved
Figure 2. Purification and Kinetic Characterization of Recombinant MetAPs from M. tuberculosis
The recombinant MtMetAP1s were overexpressed in E. coli BL21 cells and purified by affinity chromatography as described in Experimental Procedures.
(A) PolyHis-tagged-MtMetAP1c (32 kDa).
(B) PolyHis-tagged-MtMetAP1a (28 kDa). Lane 1, Molecular weight marker; lane 2, uninduced whole cell lysate; lane 3, induced cell lysate; and lane 4,
purified polyHis-tagged MtMetAP1. The gel was stained with Coomassie blue.
(C) Velocity versus substrate concentration plot forMtMetAP1a (triangles) andMtMetAP1c (squares). The kinetic constants were obtained bymeasuring enzyme
activity at different substrate concentrations. The reactions were performed in 96-well plates at room temperature and monitored at 405 nm on a UV-Vis
spectrophotometer. The total volume of reaction was 100 ml (each reaction contains 40 mM HEPES [pH 7.5], 100 mM NaCl, 1 mM CoCl2, 100 mg/mL BSA,
0.1 U/mL ProAP, and 0-800 mM Met-Pro-pNA), 334 nM MtMetAP1c, and 3.29 mM MtMetAP1a, respectively. The background hydrolysis was corrected. The
data were from quadruplet experiments and were fitted against the Michealis-Menten equation: V = Vmax3 [S] / (Km + [S]), using the Graphpad prism software
for one-site binding hyperbola.
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ence of 2,3-dichloro-1,4-naphthoquinone. Both the wild-type
and controlM. tuberculosis strainswere inhibited in the presenceChemistry & Biology 17,of 10 mg/mL 2,3-dichloro-1,4-naphthoquinone (Figure 4). In
contrast, both MtMetAP1a and MtMetAP1c knock-in strains
gained resistance to the inhibitor (Figure 4), suggesting that86–97, January 29, 2010 ª2010 Elsevier Ltd All rights reserved 89
Table 1. Kinetic Constants for MetAPs from M. tuberculosis
Kinetic Constants MtMetAP1a MtMetAP1c
Km (mM) 122 ± 22 113 ± 31
kcat/Km (M
1min1) 1.3 3 104 2.0 3 105
Vmax (mM/min) 5.1 ± 0.2 7.6 ± 0.5
The assay was performed in the presence of 1 mM CoCl2. Details of the
assay are described in Experimental Procedures.
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sequestering the inhibitor in vivo.Knockdown of MtMetAP1a, but Not MtMetAP1c, Led
to a Decrease in Growth of M. tuberculosis
It has been shown that MetAP plays an essential role in bacteria,
because knockout in E. coli and other bacteria is lethal (Chang
et al., 1989; Miller et al., 1989). Because M. tuberculosis pos-
sesses two MetAP genes, it was unclear whether knocking out
either or both of these genes in M. tuberculosis is sufficient
to inhibit growth. To study the requirement of MtMetAP1a
and MtMetAP1c for viability of M. tuberculosis, we cloned
each of the mycobacterial MetAP1s in the reverse orientation
downstream of the acetamide-regulated promoter (Pace) in
pSCW35DsigF (Figure 3A). The resulting plasmids,
pSCW35DsigF-(a-MtMetAP1a) and pSCW35DsigF-(a-MtMe-
tAP1c), were verified by sequencing. These antisense vectors,
as well as the empty control vector, were used to transform
M. tuberculosis. The three transformants were grown until early
log phase, at which point the antisense RNA was induced by
addition of 0.2% acetamide followed by incubation for an addi-
tional 24 hr. The cultures were grown for three weeks on plates
in the presence and absence of acetamide. To confirm that the
levels of both mycobacterial MetAP1s were altered, we used
real-time quantitative PCR to determine the transcript levels of
both enzymes. The mRNA levels ofMtMetAP1a andMtMetAP1c
were reduced by about 1.7- and 2.3-fold in comparison to that of
the control (Figure 3C). The colony counts after three weeks
(Table 4) showed that knockdown of MtMetAP1c in M. tubercu-
losis had a marginal effect on bacterial growth in comparison to
the control, indicating thatMtMetAP1c is probably not essential
for M. tuberculosis growth in vitro. In contrast, knockdown of
MtMetAP1a decreased the viability to 76.0% in comparison to
culture expressing the control vector (Table 4). Because MtMe-
tAP1a was only partially knocked down and the degree to which
its mRNA decreased is even less than that of MtMetAP1c, this
decrease in cell viability is significant, suggesting that MtMe-
tAP1a is likely an essential gene in M. tuberculosis and that the
inhibitory effects of the newly identified inhibitors on TB growth
was likely to be mediated by inhibition of MtMetAP1a.DISCUSSION
In this study, we applied a combination of chemical and genetic
approaches to investigate the functions of two isoforms of
MtMetAP and gathered strong evidence that MtMetAP1a is
essential for the growth ofM. tuberculosis and a promising target
for discovering and developing anti-TB agents. In addition, we
also identified naphthoquinones as an active pharmacophore90 Chemistry & Biology 17, 86–97, January 29, 2010 ª2010 Elsevierfor developing inhibitors of MtMetAP1. Inhibition of MtMetAP1a
by either small molecule inhibitors or expression of an antisense
RNA targeting MtMetAP1a led to significant inhibition of the
growth of M. tuberculosis in culture, supporting the notion that
MtMetAP1a plays an essential role in M. tuberculosis.
The availability of a number of analogs of this structural class
made possible a preliminary structure-activity relationship study.
Among a variety fo 2.3-disubstituted naphthoquinones tested,
the analogs with the highest potency contain either a chlorine
(4) or bromine (20) substituent. There is also a correlation
between the potencies of the analogs to inhibit MtMetAP
enzymes in vitro and their ability to inhibit bacterial growth.
Thus, the two most potent inhibitors of MtMetAP (4 and 20)
also exhibited the lowest MIC values for inhibition of TB culture
growth (Tables 2 and 3). Together with the antisense RNA knock-
down results, these observations provide additional evidence
that inhibition of mycobacterial growth is due to inhibition of
the MtMetAP1a.
According to genomic sequences available to date, M. tuber-
culosis possesses two MetAP-encoding genes, in contrast to
most other prokaryotes, which harbor only a single gene for
MetAP enzyme. In a previous study, biochemical purification of
MetAP enzyme from M. smegmatis yielded a single protein,
calling into question whether both of the putative MetAP genes
are expressed and, if so, whether they are bona fide MetAP
enzymes (Narayanan et al., 2008). Using RT-PCR, we were
able to detect mRNA for both MtMetAP proteins, indicating
that they are actively transcribed in M. tuberculosis. Using puri-
fied recombinantMtMetAP proteins, we demonstrated that both
MtMetAP1a and MtMetAP1c are active enzymatically, even
though MtMetAP1a is 10-fold less active. We note that while
this manuscript was under review, Zhang et al. (2009) reported
the biochemical characterization of both MetAPs fromM. tuber-
culosiswith similar observations. Where the two studies overlap-
ped, however, there are some important differences. For
example, the two MetAP proteins were found by Zhang et al.
to be similar in enzymatic activity. The optimal temperature,
metal ion concentrations, and pH for the recombinant proteins
also differ to some extent. It is noteworthy that different assays
were used in the two studies.We used a contiguous spectropho-
tometric assaywithMet-Pro-pNA as a substrate, but Zhang et al.
used methionine-containing oligopeptides as substrates (Zhang
et al., 2009). The distinct substrates and the accompanying
assay conditions may account for most, if not all, of the qualita-
tive differences in kinetic parameters and temperature and pH
dependence observed in the two studies.
The unique presence of two isoforms ofMetAP enzymes in TB,
in contrast to the majority of other prokaryotes, called into ques-
tion whether one or both isoforms are essential for the viability of
themycobacteria. To assess this question, we performed a high-
throughput screen againstMtMetAP1c and identified a family of
structurally related inhibitors sharing a common 1,4-napthoqui-
none core. Although evaluation of additional structural analogs
led to the identification of more potent inhibitors ofMtMetAP1c,
none of the inhibitors of this structural class is selective toward
eitherMtMetAP1c orMtMetAP1a. The lack of isoform specificity
is consistent with the observation that overexpression of either
MtMetAP isoform conferred resistance to the inhibitor. The
nonselective MtMetAP inhibitors were capable of inhibitingLtd All rights reserved
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MtMetAP enzymes are essential for bacterial growth, leaving
unanswered the question of whether the growth inhibition was
mediated through one or both isoforms of MtMetAP. Using
knockdown with specific antisense RNA, we found that knock-
down ofMtMetAP1a, rather thanMtMetAP1c, slowed growth of
M. tuberculosis in culture, which suggests that inhibition of
MtMetAP1amay be responsible for growth inhibition by the small
molecule inhibitors. However, these results are also consistent
with an alternative possibility that the two MetAP1 proteins are
functionally redundant and inhibition of both enzymes mediated
the growth inhibition by the nonselective small molecule inhibi-
tors. It is worth pointing out that both MtMetAP genes have
been previously predicted to be essential for M. tuberculosis
survival in vivo andpathogenicity (Ribeiro-Guimaraes andPesso-
lani, 2007). Together with the previous observation that the two
genes are optimally expressed at different growth phases of M.
tuberculosis (Zhang et al., 2009), it is possible that only MtMe-
tAP1a is required for growth in culture medium in vitro. The pres-
ence of multiple isoforms of MetAP-encoding genes has also
been seen in some other pathogenic microorganisms. For
example, Bacillus anthracis possesses three putative MetAP
genes, and malaria contains four different isoforms of MetAPs
(Chen et al., 2006). In comparison to most prokaryotes,M. tuber-
culosis is also unique in that it has to evade and propagate within
human microphages. It will be interesting to determine whether
MtMetAP1c may play a role in the survival of M. tuberculosis
within mammalian cells.
Of the two MtMtMetAP enzymes, MtMetAP1c contains an
N-terminal ‘‘linker’’ region, whereas MetAP1a is free of the
N-terminal domain similar to other prokaryotic MetAP enzymes
(Figure 1). Using nearly homogeneous recombinant proteins,
we found that MtMetAP1a is catalytically 10-fold less active
than MtMetAP1c. This difference in activity appeared to be
due to the use of the artificial tripeptide substrate, because
similar activities were found when oligopeptide substrates
were used (Zhang et al., 2009). In addition, we also observed
some difference in thermostability, optimal pH, and dependence
on metal ions. In comparison with MtMetAP1c, MtMetAP1a has
a lower optimal temperature, a broader range of optimal pH
values spanning one unit of pH, and a higher threshold of activa-
tion by metal ions. Although MtMetAP1c contains an N-terminal
SH3 ligand-containing extension, MetAP1a contains an internal
insertion of six amino acids, in comparison with MetAP1c and
human MetAP1. These differences in primary structure and the
accompanying tertiary structures may account for part of the
differences in activity, substrate specificity, and other biochem-
ical properties of the twoMtMetAPs. It also raised the possibility
of identifying inhibitors that are specific for MtMetAP1a over
MtMetAP1c or human MetAP1 as leads for anti-TB drugs.
SIGNIFICANCE
The emergence of multidrug-resistant and extensively drug-
resistant Mycobacterium tuberculosis strains has imposed
a pressing need for antimycobacterials with novel mecha-
nisms of action. Methionine aminopeptidases are evolution-
arily conserved enzymes, and they play essential roles for
the viability of both prokaryotes and eukaryotes. The func-Chemistry & Biology 17,tional importance of MetAP in M. tuberculosis, however,
remained unclear, as it possesses two genes, MtMetAP1a
and MtMetAP1c. By overexpressing each isoform in E. coli
and purifying them to near homogeneity, we demonstrated
that both recombinant MtMetAP proteins are enzymatically
active. Furthermore, quantitative RT-PCR analysis revealed
that both proteins are expressed, at least at the mRNA level,
in stationary cell culture. Using high-throughput screening,
we identified inhibitors of both enzymes, which also in-
hibited the growth of mycobacteria in culture. Using anti-
sense RNA, we found that the two isoforms are not function-
ally redundant. Although the more active MtMetAP1c is
dispensable, MtMetAP1a appears to be required for myco-
bacterial growth in culture. Thus, MtMetAP1a can serve as
a target and the naphthoquinone-containing inhibitors can
serve as leads for the development of new anti-TB agents.
EXPERIMENTAL PROCEDURES
Materials
The vectors pET28a and pET28b and the E. coli BL21 expression host
were purchased from Novagen. The expression vector pSCW35DsigF, a
pMH94-based vector, was constructed by Dr. Sam Woolwine. The iScript
cDNA synthesis kit and the SYBR Green Supermix were purchased from Bio-
Rad Laboratories. The M. tuberculosis cultures medium, Middlebrook 7H9,
was purchased from Becton Dickinson. The Talon resin was from Clontech.
Isopropyl b-D-thiogalactopyranoside (IPTG) was purchased from Sigma
Aldrich. The structurally diverse compound library was provided by ASDI.
Subcloning of the Two MetAPs from M. tuberculosis
The N-terminal polyHis-tag MtMetAP1c gene was amplified by polymerase
chain reaction (PCR) from M. tuberculosis (CDC1551) genomic DNA using
Taq polymerase. The M. tuberculosis (CDC1551 strain) genomic DNA was
generously provided by Dr. William Bishai. The primers used were 50-GCG
GGA TCC CCT AGT CGT ACC GCG CTC30 and 50-GCG CTC GAG CTA
CAGACAGGTCAGGATC-30 for forward and reverse directions, respectively.
The PCR fragments were cloned into pET28a, using the BamHI and XhoI
restriction sites, respectively.
The C-terminal polyHis-tag MTMAP1A gene was amplified by PCR from
pET28a (MtMAP1a) plasmid (this plasmid was also subcloned from M. tuber-
culosis genomic DNA generously provided by Dr. William Bishai). The primers
used were 50-GCG CCA TGG GCC CAC TGG CAC GGC TGC GGG GTC30
and 50-GCG CTC GAG ACC GAG CGT CAG AAT TCG GGG CCC-30 for
forward and reverse directions, respectively. The PCR fragments were cloned
into pET28b, using the NcoI and XhoI restriction sites, respectively. Both
MtMetAP1a and MtMetAP1c clones were confirmed by sequencing.
Overexpression and Purification of Recombinant MetAP
from M. tuberculosis
E. coli BL21 cells (DE3) containing the expression plasmid were cultured at
37C in 1 liter of Listeria broth (LB) containing 30 mg kanamycin until OD600
reached about 1.0. The expression of MtMetAP1a was induced by addition
of isopropyl b-D-thiogalactopyranoside (IPTG) to a final concentration of
1 mM followed by continued shaking of the culture flask at 280 rpm, at 16C
for 48 hr. The cells were harvested and washed with 13 PBS (137 mM NaCl,
2.7 mM KCl, 4.3 mM Na2HPO4.7H2O, and 1.4 mM KH2PO4 [pH 7.3]). The
cells were sonicated in +TG buffer (50 mM HEPES [pH 8.0], 0.5 M KCl, 10%
glycerol, 5 mM imidazole, and 0.1% Triton X-100) with EDTA-free protease
inhibitor tablets. The resulting lysate was centrifuged at 80003 g for 10 min.
The supernatant was loaded onto pre-equilibrated (+TG buffer) Talon resin
(Clontech). After equilibration for 30 min, the beads were washed three times
withTG buffer (50 mMHEPES [pH 8.0], 0.5 M KCl, and 5 mM imidazole). The
enzyme was eluted with 100 mM imidazole in TG buffer. The protein was
quantified using the Bradford assay. The average yield for MtMetAP1a was
4.3 mg/l of culture.86–97, January 29, 2010 ª2010 Elsevier Ltd All rights reserved 91
Table 2. Effect of Naphthoquinones onMtMetAPsFx1
O
O
R1
R2
R3 IC50 (mM)
ID R1 R2 R3 MtMetAP1a MtMetAP1c
2 N
O
O
C l
C l
C l
C l
Cl H 4.0 ± 0.3 8.7 ± 0.2
3 N Cl H 8.0 ± 1.31 7.2 ± 1.8
4 Cl Cl H 3.3 ± 0.3 6.6 ± 1.2
5 NH2 Cl H >100 >100
6 NH
Cl
Cl H >100 >100
7
N
N Cl H >100 >100
8 N
N
Cl
Cl H >100 >100
9 N
N
Cl
C l
Cl H >100 >100
10 N
N
Cl Cl H >100 >100
12
CF3
NH
Cl H >30 >50
13
F
NH
Cl H >30 >50
14
NH
O
O
Cl H >30 >50
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Table 2. Continued
O
O
R1
R2
R3 IC50 (mM)
ID R1 R2 R3 MtMetAP1a MtMetAP1c
15
NH
N
Cl H >30 >50
16
NH
Cl H >50 >50
17
NH
Cl H 18.6 ± 6.1 21.3 ± 10.6
18
NH
O
Cl H 15.9 ± 06 22.5 ± 1.5
19
NH
Cl H 13.9 ± 1.0 16.4 ± 6.8
20 Br Br H 1.14 ± 0.25 0.71 ± 0.02
21
O
F
O
F
H 4.93 ± 0.20 1.79 ± 0.49
22
O
F
Cl H 7.58 ± 0.28 3.74 ± 0.52
23 H H OH >50 >30
24 CH3 H OH >50 >50
25 OH H H >50 >50
26 N Cl H >50 >30
27
O
NH
CF3
CF3
Cl H >50 >50
28 CH3 H >50 >50
29 CH3 H H >50 >50
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Table 3. Activity ofMtMetAP Inhibitors on M. tuberculosis
Minimum Inhibitory Concentration (mg/mL)
Compound
Identification Number
Replicating
M. tuberculosis
Aged-cultureda
M. tuberculosis
2 25 23.8
3 >25 >27.6
4 10 5.7–11.4
20 10.0–25 ND
21 >25 ND
22 >25 ND
ND, not done.
a Nonreplicating M. tuberculosis.
Figure 3. Overexpression of MtMetAP1a and MtMetAP1c Confers
Resistance to Inhibitors
(A) Schematic representation of plasmids used for target validation. (i) Control
plasmid pSCW35DsigF; (ii) sense construct: pSCW35DsigF-(MtMetAP1); and
(iii) anti-sense construct: pSCW35DsigF-(a-MtMetAP1). The MtMetAP genes
were inserted downstream of the acetamide regulated promoter (Pace).
(B and C) The expression of MtMetAP1a and MtMetAP1c mRNA in M. tuber-
culosis as determined by quantitative RT-PCR. The levels of MtMetAP1a
and MtMetAP1c were determined in M. tuberculosis strains transformed
with vectors overexpressing the two genes in the sense (A-ii) and antisense
(A-iii) orientation, respectively. The quantities of mRNA are shown as fold
change compared to the expression in the wild-type with standard error
from two independent experiments.
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in 1 liter of LB containing 30 mg kanamycin until OD600 reached about 0.6–0.7.
The expression was induced by addition of IPTG to a final concentration of
1 mM followed by shaking the culture flask at 37C, and 275 rpm for 4 hr.
The cells were harvested and washed with 13 PBS. The cells were sonicated
in 1X PBS with 0.2% Triton X-100 and EDTA-free protease inhibitor tablets.
The resulting cell free lysate was centrifuged at 80003 g for 10 min. The super-
natant was loaded onto pre-equilibrated (13 PBS) Talon resin (Clontech). After
equilibration for 30 min, the beads were washed three times with basic buffer
(10 mM HEPES [pH 8.0], 100 mM KCl, 1.5 mMMgCl2, and 10% glycerol). The
enzyme was eluted with 75 mM imidazole in basic buffer. The protein was
quantified using the Bradford assay. The average yield for MtMetAP1c was
13.2 mg/l of culture.
Determination of Kinetic Constants of MtMetAPs
The kinetic constants of the mycobacterial MetAPs were determined using
a coupled methionine-proline aminopeptidase assay developed by Dr. Dehua
Pei at The Ohio State University (Zhou et al., 2000). The substrate used in this
assay is a dipeptide, methione-proline coupled to p-Nitroaniline. The dipeptide
substrate, Met-Pro-pNA, was synthesized by Dr. Keechung Han. The kinetic
constants were obtained by measuring enzyme activity at different substrate
concentrations. The reactions were performed in 96-well plates at room
temperature and monitored at 405 nm on a spectrophotometer. The total
reaction volume was 100 ml, and each reaction contained 40 mM HEPES
buffer (p.H 7.5), 100 mM NaCl, 1 mM CoCl2, 100 mg/mL BSA, 0.1 U/mL ProAP,
0–800 mM substrate (Met-Pro-pNA), 334 nM MtMetAP1c, and 3.29 mM
MtMetAP1a, respectively. The background hydrolysis was corrected, and
the data were fitted against the Michealis-Menten equation: V = Vmax 3 [S] /
(Km + [S]), using the Graphpad prism software for one-site binding hyperbola.
High-Throughput Screening for MtMetAP1c Inhibition
We screened about 175,000 compounds against MetAP1c at concentrations
of 30 mM in 384-well plates, using the dipeptide substrate. The compounds
were dissolved in dimethylsulfoxide (DMSO). The initial screen was conducted
using a titertek instrument with liquid handling capabilities coupled to a spec-
trophotometer. The total reaction volume was 50 ml, and each reaction
contained 40 mM HEPES buffer (pH 7.5), 100 mM NaCl, 100 mg/mL BSA,
0.1 U/mL ProAP, 1.5 mM CoCl2, 600 mM substrate (Met-Pro-pNA), and
252 nM MtMetAP1c. The enzyme was preincubated with compounds for
20 min at room temperature followed by addition of 600 mM substrate. The
reaction was incubated at room temperature for 30 min and monitored at
405 nm on a spectrophotometer. The Compounds that showed greater than
30%–40% inhibition were chosen as ‘‘hits.’’
Determination of IC50 of Inhibitors of MtMetAP1 and Clustering
of Structural Classes of Inhibitors (ASDI-ISIS)
We determined the concentration needed for 50% inhibition in 96-well plates
at final concentrations ranging from 100 mM to 300 nM (for 81 compounds that
were available in larger quantities). The total reaction volume was 50 ml, and
each reaction contained each MtMetAP1, respectively, and 40 mM HEPES94 Chemistry & Biology 17, 86–97, January 29, 2010 ª2010 Elsevierbuffer (p.H 7.5), 100 mM NaCl, 100 mg/mL BSA, 0.1 U/mL ProAP, 1.5 mM
CoCl2, and 600 mM substrate (Met-Pro-pNA). The enzyme was preincubated
with compounds for 20 min at room temperature followed by addition of
substrate. The reaction was incubated at room temperature for 30 min and
monitored at 405 nm on a spectrophotometer. The background hydrolysis
was corrected, and the data were fitted against the sigmoidal-dose response
(variable slope) equation using GraphPad prism software.Determination of Minimum Inhibitory Concentration in
M. tuberculosis
The primary screen against replicating M. tuberculosis was conducted with
14 MtMetAP inhibitors at concentrations ranging from 50 to 0.05 mg/ml. TheLtd All rights reserved
Figure 4. Target Validation of Naphthoquinone In Vivo
M. tuberculosis knock-in strains containing MtMetAP1a, MtMetAP1c, or
control expression plasmid were grown in liquid media in the presence (A)
or absence (B) of 10 mg/mL compound 4 and DMSO. Symbols: MtMetAP1a,
diamonds; MtMetAP1c, squares; wild-type strain, stars; and sigma factor-F
lacking mutant, triangles.
Table 4. Viability of Knockdown Strains ofM. tuberculosis
Knockdown Construct Viability (%)
pSCW35-(a-MtMetAP1a) 76.0 ± 4.0
pSCW35-(a-MtMetAP1c) 95.3 ± 4.7
pSCW35DsigF 94.6 ± 4.4
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OADC (without Tween 80) to give final concentrations of 50, to 0.05 mg/ml.
A culture of M. tuberculosis H37Rv was grown to an OD of 1.0, and diluted
to 1/100. Then each tube containing compound was inoculated with 0.1 ml
of culture to give a total assay volume of 5 ml. The controls were DMSO, Isoni-
azid (a positive control) and a blank (drug free media). The 15-ml conical assay
tubes containing mycobacteria were incubated at 37C and in 5% CO2.
Formation of granulation was monitored for two weeks.
Activity of Inhibitors on Aged Nongrowing M. tuberculosis
The primary screen against non-replicating M. tuberculosis was conducted
with 21MtMetAP inhibitors against non-replicatingM. tuberculosis at concen-
trations ranging from 0.5 to 100 mM for three weeks. The screen against aged-
culturedM. tuberculosiswas conducted using a persister model, as described
by Byrne et al. (2007). Briefly, a 2-month-old M. tuberculosis H37Ra culture
grown in 7H9 medium (Difco) with 10% albumin-dextrose-catalase (ADC)
and 0.05% Tween 80 was resuspended in acid 7H9 medium (pH5.5) without
ADC. The bacterial cell suspension was used as inocula for assaying the
activity of the compounds for persister bacilli. The compounds were diluted
from the stock solution (10 mM in DMSO) to 10 mM (final) followed by incuba-
tion with the bacilli in 200 ml in acidic (pH 5.5) 7H9 medium without ADC in 96-
well plates for 3 days without shaking under 1% oxygen in a hypoxic chamber.
The assay was done in duplicate. Rifampin (5 mg/ml) was used as a positive
control. After 3-day drug exposure, the viability of the bacilli was determined
by adding 20 ml of 1 mg/ml XTT (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-Chemistry & Biology 17,2H-tetrazolium-5-carboxanilide) and incubated at 37C up to 7 days when the
plates were read at OD 485 nm.
Subcloning of MtMetAP1a and MtMetAP1c into pSCW35DsigF
The entire ORFs ofMtMetAP1a andMtMetAP1c geneswere amplified by poly-
merase chain reaction (PCR) in the sense orientation from M. tuberculosis
strain CDC1551 genomic DNA. Then, we cloned the PCR fragments into
pSCW35 vector, using the NdeI and PacI restriction sites. The primers used
were as follows: for MtMetAP1a, forward 50-CGCATTAATGCCCACTGG
CACGGCTGCGGGGTC-03 and reverse 50 CCTTAATTAACTAACCGAGCGTC
AGAATTCGGGGC-03; forMtMetAP1c, forward 50-GGAATTCCATATGCCTAG
TCGTACCGCGC-03 and reverse 50-CCTTAATTAACTACAGACAGGTCAGG
ATC-03. The pSCW35DsigF-(MtMetAP1a) and pSCW35DsigF-(MtMetAP1c)
clones were verified by DNA sequencing.
Overexpression of MtMetAP1a and MtMetAP1c in M. tuberculosis
in the Presence of Inhibitor
Weconstructed knock-in strains of bothMtMetAP1s by transformingM. tuber-
culosis CDC 1551 with pSCW35DsigF-(MtMetAP1a) and pSCW35DsigF-
(MtMetAP1c), respectively. In addition, we transformed M. tuberculosis with
a control plasmid, pSCW35DsigF, which is an empty vector kindly provided
by Dr. Tirumalai. All three transformants were grown until early log phase
and expression was induced by addition of 0.2% acetamide followed by
incubation for 24 hr. We diluted the cells to an OD600 of 0.05 and cultured
them separately in the presence of 10 mg/ml 2,3-dichloro-1,4-naphthoquinone
or DMSO. Then growthwas followed by recordingOD600 every 24 hr for 7 days.
The M. tuberculosis cultures were grown in Middlebrook 7H9 medium and
supplemented with 2% glycerol, 0.05% Tween-80, and 10% albumin/
dextrose complex (ADC).
Subcloning of Antisense of MtMetAP1a and MtMetAP1c
into pSCW35DsigF
To study the requirement of MtMetAP1a and MtMetAP1c for growth and
survival of M. tuberculosis, we cloned each of the mycobacterial MetAP1s in
the reverse orientation downstream of the acetamide regulated promoter
(Pace) in pSCW35DsigF. The entire ORFs of MtMetAP1a and MtMetAP1c
genes were amplified by polymerase chain reaction (PCR) in the antisense
orientation from M. tuberculosis strain CDC1551 genomic DNA. Then, we
cloned the PCR fragments into pSCW35DsigF vector, using the NdeI and
PacI restriction sites. The pSCW35DsigF -(a-MtMetAP1a) and pSCW35DsigF
-(a-MtMetAP1c) clones were verified by restriction digestion and DNA
sequencing.
Knockdown of MtMetAP1a and MtMetAP1c in M. tuberculosis
We constructed knockdown strains of both MtMetAP1s by transforming
M. tuberculosis CDC 1551 with the antisense constructs: pSCW35DsigF
-(a-MtMetAP1a) and pSCW35DsigF -(a-MtMetAP1c). Then, we transformed
M. tuberculosiswith a control plasmid, pSCW35DsigF. All three transformants
were grown until early log phase, and expression was induced by addition of
0.2% acetamide for 24 hr. Then the cultures were grown for three weeks on
plates in the presence and absence of acetamide. TheM. tuberculosis culture
plates (Middlebrook 7H10 agar) were supplemented with 5% glycerol and
10% ADC. The colony counts were conducted after three weeks, and
percentage of viability was determined using the following formula: Viability
% = 100 3 [number of colonies on 7H10 K15 + 0.2% acetamide / number of
colonies on 7H10 K15].
Mycobacterial RNA Isolation
To confirm that the levels of both mycobacterial MetAP1s were altered as
expected, we extracted RNA from the acetamide-induced transformants86–97, January 29, 2010 ª2010 Elsevier Ltd All rights reserved 95
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enzymes, as described below. M. tuberculosis cultures containing plasmids
overexpressing sense and antisense constructs of MtMetAP1a and MtMe-
tAP1c and the control plasmid pSCW35DsigF were grown to exponential
phase and induced with 0.2% acetamide for 24 hr. Following induction, cells
were pelleted by centrifugation at 3000 rpm for 10 min. The pellet was washed
once with PBS and resuspended in 1 ml of Trizol reagent (Invitrogen Technol-
ogies) in 2 ml O-ring tubes. Cells were lysed by eight bead beating cycles of
30 s each (with 0.1 mm silica zirconia beads; Biospec Products), on a bead
beater (Biospec Products). The tubes were then centrifuged at 13,000 rpm
for 5 min to recover the supernatant; the beads and cell debris were discarded
at this point. Two hundred microliters of chloroform was added to the super-
natant and centrifuged at 13,000 rpm for 5 min following a 30 s vortex cycle.
To precipitate the RNA, one volume of isopropanol was added to the aqueous
phase, mixed, and incubated at RT for 10 min. RNA was pelleted by centri-
fuging at 13,000 rpm for 10 min at 4C. The pellet was washed twice with
70% ethanol and dried at RT. The RNA samples were resuspended in DEPC
water and quantitated by measuring A260. The quality of the RNA was
assessed by the A260 /A280 ratio and by agarose gel electrophoresis.
Real-Time PCR Analysis
To quantitate transcript levels of MtMetAP1a and MtMetAP1c under condi-
tions where the levels of the genes was being perturbed, RNA was isolated
from the acetamide-induced cultures (as described above), treated with
RNase-free DNase (Ambion) and 0.5 mg of RNA, and subjected to reverse
transcription using the iScript cDNA synthesis kit (Biorad). This was followed
by real-time quantitative PCR using the SYBRGreen Supermix (Bio-Rad Labo-
ratories). MtMetAP1a and MtMetAP1c were amplified using gene specific
primers; both sets of primers amplify 200 nt of the respective gene. The
primers used were as follows: for MtMetAP1a, forward 50-CCGAGGTGCTC
GCGCCCGGTG-30and reverse 50-TTCGATGGCATGCGCGACG-30; and
for MtMetAP1c, forward 50-GCTGGGCTACAAGGGATTCCCGAAG-30 and
reverse 50 TCCGGTCAACGAGCAACCGGTG-30. The relative fold change of
mRNA of the two genes under each of the experimental conditions was
measured by normalizing its transcript level to that of M. tuberculosis sigma
factor A (sigA). The fold differences in transcript levels were derived by
comparing the Ct values in the test (sense 1a, sense 1c, antisense 1a, and
antisense 1c) samples with that of the control sample (pSCW35DsigF).
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